MedTrace Logo

CSD1603: A Crossover Study to Evaluate the Exposure to "Tar" and Nicotine From 100s Menthol Cigarette Products

NCT03063047 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2017-03-14

No results posted yet for this study

Summary

This study will evaluate exposure to "tar" and nicotine from two menthol cigarette products and provide a basis for comparing mouth-level exposure when smokers smoke the two cigarette products. Mouth-level exposure is the measurement of substance trapped in the cigarette butt after smoking the cigarette.

Other purposes of this study are to:

* Compare the plasma cotinine, a byproduct of your body's processing of nicotine, levels found in users after smoking each of two different cigarettes.
* Find out the daily mouth-level exposure to cigarette "tar" and nicotine from smoking each of two different cigarettes in adult smokers.
* Determine if certain measures of nicotine dependence change based on the type of cigarette smoked
* To compare product liking and intent to use it again.

Conditions

  • Smoking

Interventions

OTHER

PD21871AA

A 100s size menthol cigarette.

OTHER

PD21872AA

A 100s size menthol cigarette.

Sponsors & Collaborators

  • Davita Clinical Research

    collaborator INDUSTRY

  • RAI Services Company

    lead INDUSTRY

Principal Investigators

  • Elizabeth Yoon, FNP-C · Davita Clinical Research

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-06
Primary Completion
2017-03-13
Completion
2017-03-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03063047 on ClinicalTrials.gov